Cytek Biosciences, Inc. CTKB Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total revenue, net by Geography | |||||
| APAC | $41.08M+14.8% | $35.77M+21.0% | $29.56M+31.2% | $22.52M+40.1% | |
| China | $20.5M— | —— | —— | —— | |
| EMEA | $55.88M-10.4% | $62.34M+20.5% | $51.75M+17.7% | $43.96M+18.9% | |
| Other | $9.28M-4.7% | $9.73M+49.6% | $6.51M+120% | $2.96M-97.7% | |
| United States | $95.26M+2.8% | $92.66M-11.9% | $105.21M+11.2% | $94.59M+30.1% | |
| Total by Geography | |||||
| APAC | $38.02M+3.2% | $36.85M+15.1% | $32.03M+150% | $12.83M— | |
| EMEA | $1.76M-3.0% | $1.82M— | —— | —— | |
| United States | $32.46M-5.0% | $34.16M-1.3% | $34.61M+53.5% | $22.54M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytek Biosciences, Inc. break its business down?
- Cytek Biosciences, Inc. (CTKB) reports total revenue, net by geography across 5 parts — APAC, China, EMEA, Other and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytek Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytek Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
